LEVELS OF COMPLEMENT FACTOR-C3 AND ITS ACTIVATED PRODUCT, C3A, IN OPERATIVELY SALVAGED BLOOD

被引:3
|
作者
SIEUNARINE, K
WETHERALL, J
LAWRENCEBROWN, MMD
GOODMAN, MA
PRENDERGAST, FJ
HELLINGS, M
机构
[1] Departments of Vascular Surgery, Royal Perth Hospital, Perth, Western Australia
[2] Departments of Anaesthesia, Royal Perth Hospital, Perth, Western Australia
[3] Curtin University, Perth, Western Australia
来源
关键词
AUTOTRANSFUSION; COMPLEMENT FACTORS;
D O I
10.1111/j.1445-2197.1991.tb00216.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
In intra-operative blood salvage the collected blood is exposed to traumatized tissue and a synthetic circuit. Because of this exposure it was expected that the complement system, which is a contact system present in plasma, would be activated in salvaged blood. To determine whether this occurs, the plasma levels of the complement factor C3 and its activated fragment, C3a, were measured in intra-operative salvaged blood before and after washing. Samples were obtained from patients undergoing aortic surgery where intra-operative salvage was used. In the unwashed salvaged blood, the level of C3 fell (mean C3: 0.33g/L) and the level of C3a increased (mean C3a: 1944 ng/mL) compared with the patient circulating levels of C3 and C3a (mean C3:0.70 g/L, mean C3a: 855 ng/mL) respectively. Washing of the collected blood reduced the C3a level (mean:346 ng/mL) to the patient's level and reduced C3 to the lower detection limit of the test (< 0.2 g/L). The raised level of C3a and the reduced level of C3 confirm that the complement system is activated and imply that other complement factors are also activated.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 50 条
  • [1] PHOSPHORYLATION OF COMPLEMENT FACTOR-C3 INVIVO
    MARTIN, SC
    BIOCHEMICAL JOURNAL, 1989, 261 (03) : 1051 - 1054
  • [2] PRODUCTION OF COMPLEMENT CLEAVAGE PRODUCT, C3A, BY ACTIVATED MACROPHAGES AND ITS TUMOROLYTIC EFFECTS
    FERLUGA, J
    SCHORLEMMER, HU
    BAPTISTA, LC
    ALLISON, AC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 31 (03): : 512 - 517
  • [3] EFFECT OF SULFIDE IONS ON COMPLEMENT FACTOR-C3
    GRANLUNDEDSTEDT, M
    JOHANSSON, E
    CLAESSON, R
    CARLSSON, J
    INFECTION AND IMMUNITY, 1991, 59 (02) : 696 - 699
  • [4] PURIFICATION AND CHARACTERIZATION OF EQUINE COMPLEMENT FACTOR-C3
    BOSCHWITZ, JS
    TIMONEY, JF
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 38 (1-2) : 139 - 153
  • [5] PHOSPHORYLATION DEPHOSPHORYLATION AND THE REGULATION OF FIBRINOGEN AND COMPLEMENT FACTOR-C3
    FORSBERG, PO
    MARTIN, SC
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1991, 96 (02) : 75 - 93
  • [6] STUDIES ON THE BINDING OF COMPLEMENT FACTOR-C3 TO THE SURFACE OF HUMAN-BLOOD PLATELETS
    ENDRESEN, GKM
    MELLBYE, OJ
    HAEMOSTASIS, 1984, 14 (03) : 269 - 280
  • [7] CYTOLYTIC EFFECTS OF COMPLEMENT CLEAVAGE PRODUCT, C3A
    FERLUGA, J
    SCHORLEMMER, HU
    BAPTISTA, LC
    ALLISON, AC
    BRITISH JOURNAL OF CANCER, 1976, 34 (06) : 626 - 634
  • [8] Complement C3a levels and misinterpretation of classifier technology
    Mario Petretta
    Inflammation Research, 2017, 66 : 281 - 282
  • [9] Complement C3a levels and misinterpretation of classifier technology
    Petretta, Mario
    INFLAMMATION RESEARCH, 2017, 66 (04) : 281 - 282
  • [10] The Complement C3a and C3a Receptor Pathway in Kidney Diseases
    Gao, Shuang
    Cui, Zhao
    Zhao, Ming-hui
    FRONTIERS IN IMMUNOLOGY, 2020, 11